VAERS Explorer
Back to explore

Report #2851447

Received Jul 28, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
MD
Recovered
Unknown
Vaccinated
Jul 21, 2025
Onset
Jul 21, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (HEPLISAV-B)DYNAVAX TECHNOLOGIES CORPORATIONUNK——

Symptoms (1)

Product administered to patient of inappropriate age

Symptom narrative

16-Year-Old Patient Received HEPLISAV-B; Initial report received on 21-Jul-2025. A pharmacist reported that a 16-year-old patient received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization. No medical history or concomitant medications were reported. On 21-Jul-2025, the patient received a dose of a hepatitis B vaccine HEPLISAV-B (lot number, expiration date, NDC number, route, and site not available). The patient was 16 years old at the time of administration. No other information was available. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.